Pharmafile Logo

The Clinical Trial Company

The Clinical Trial Company (TCTC) targets medium size clinical trials and novel products which lack a classical road map to the market.
Large CROs prioritise studies from the big pharma companies, for good business reasons. However, this approach sometimes disadvantages their SME clients who are equally keen to complete their clinical trials quickly. TCTC are experts in advanced therapies, such as cell and gene therapies, as well as orphan drug and biologics.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Company Details

Mere View Barn, Park Lane, Pickmere, Knutsford, WA16 0LG, UK
+44 1565 733 772

 Latest Content from PMHub 

Report: Achieving launch excellence in the challenging healthcare markets of today

Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

NHS medicines optimisation milestone

Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry

What is blockchain and why should i care – Richard Springham

Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Lucid Group celebrate another magical year at their Winter Meeting

2018 has without doubt been a stellar year for Lucid Group, scooping a double win at Communiqué - winning both Communiqué Medical Education Consultancy of the Year and Communiqué Communications...

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?

What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?

What everyone forgets about good organisational change in pharma

Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account.

Modernising the Mental Health Act: Published Today

Press Releases | December 6, 2018 | Mednet

The final report of the Independent Review of the Mental Health Act 1983 has been published today, 6th December 2018.

Lucid Group welcomes new magical talent and boosts their medical writing teams with hires in the US and UK

Lucid group welcomes four new additions to their medical writing family, with new hires across the UK and USA.Sonal Adhav joins Lighthouse Medical Communications US as a Senior Scientific Director...

Live from Singapore: Oncology in APAC – Evaluating the opportunity for novel therapies

White Papers and Resources | December 4, 2018 | Inizio

Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST